News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt     2/20/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study     2/16/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force     2/15/2017
H. Lundbeck A/S (LUN.CO) Throws in the Towel on Alzheimer's Pill, Giving Leeway to Rival Axovant (AXON)     2/8/2017
Eli Lilly (LLY) Washes Its Hands of Another Phase 3 Study After the Failure of Solanezumab     2/2/2017
The 7 Worst Clinical Disasters of 2016     12/27/2016
Acadia (ACAD) Stock Screams Upward; Primary Endpoint Met in Phase II Study of Pimavanserin for Alzheimer’s     12/21/2016
Investors Sigh With Relief as Biogen (BIIB)'s Alzheimer's Drug Delivers in Early-Stage Study     12/15/2016
As Biogen (BIIB)'s Drug Shines, Eli Lilly (LLY) Releases Detailed Results of Its Own Failure Solanezumab     12/9/2016
All Eyes Will Be on Biogen (BIIB) and Its Much-Anticipated Alzheimer's Data Tomorrow     12/9/2016
Fear of Layoffs Loom Over Eli Lilly (LLY) Employees After Alzheimer's Setback     12/1/2016
Devastation Hits as Eli Lilly (LLY)'s Alzheimer's Drug Flunks Late-Stage Study, Shares Tank     11/29/2016
Investors Remain Bullish Over Biogen (BIIB)'s Risky Alzheimer's Drug Despite Eli Lilly (LLY) Setback     11/28/2016
Former Allergan (AGN) Exec Who Now Helms Chase Pharma Inks $1 Billion Pact With Brent Saunders and His New Gang     11/28/2016
5 Drug Giants That Could Dominate the $13 Billion Alzheimer's Market     11/23/2016

News from Around the Web
Will BACE Inhibitors Help Alzheimer's Patients?     2/24/2017
Merck & Co. (MRK)'s Alzheimer's Failure Has All Eyes and Hopes Turning to Biogen (BIIB)     2/16/2017
Alzheimer's Causes: Could Refined Sugar Lead To Dementia, Cognitive Decline?     2/14/2017
6 Unexpected Ways To Decrease Your Risk Of Alzheimer’s     2/13/2017
NeuroEM Medical Device Could Be Major Breakthrough For People With Alzheimer's, Banner Health Study Reveals     2/1/2017
From Psychedelics To Alzheimer's, 2016 Was A Good Year For Brain Science     1/3/2017
Following Eli Lilly (LLY)'s Failure, What's Next In Alzheimer's Treatments?     12/19/2016
Treating Alzheimer’s Disease With Brain Waves, Study Published In Nature     12/9/2016
Catalyst Driver For PDL BioPharma (PDLI) Is Coming     11/18/2016
Alzheimer’s Didn’t Cause Memory Loss For These Superaging 90-Year Olds, Northwestern University Feinberg School of Medicine Study     11/17/2016
Eli Lilly (LLY)'s Solanezumab And The History Of The Future Of Treating Alzheimer's Disease     11/11/2016
Baylor College of Medicine Take First Steps Toward A Preventative Alzheimer's Pill     10/25/2016
University of Pennsylvania Psychiatrist Questions Whether Antidepressants Prevent Alzheimer's     10/10/2016
Genetic Score Predicts Age-Related Risk Of Alzheimer's Disease, University of California, San Diego (UCSD) Study Says     10/5/2016
Eli Lilly (LLY)'s Alzheimer's Drug Could Potentially Bring in Billions     9/28/2016

Press Releases
ProMis Neurosciences Issues White Paper Entitled "Results From Recent Alzheimer's Disease Trials Validate The Promis Approach"     2/22/2017
WhatBox Release: New iStand Walking Cane With SmartWalk Technology to Revolutionize Healthcare For Senior Citizens and Those With Alzheimer's And Dementia     2/22/2017
Bionomics Limited (BNO.AX) To Receive Milestone Payment From Merck & Co. (MRK) For Initiation Of Phase I Clinical Study Of Candidate Alzheimer's Treatment     2/3/2017
Alzamend Neuro Release: University of South Florida Researcher Develops Therapeutic Vaccine To Combat Alzheimer’s Disease And Neurodegenerative Disorders     1/30/2017
AbbVie (ABBV) Release: Pharma Initiates Phase 2 Clinical Trial Programs For ABBV-8E12, An Investigational Anti-Tau Antibody, In Early Alzheimer's Disease And Progressive Supranuclear Palsy     1/25/2017
Alzheimer's Research Foundation Release: Fisher Center Scientists Link A Mutation That Protects Against The Development Of Alzheimer's Disease To The Effect Of Gleevec     1/24/2017
Saladax Biomedical Inc. (SBI) Release: Company Licenses Alzheimer’s Diagnostic Tests To Siemens Healthineers (SI)     1/18/2017
Selonterra Release: Biotech Publishes Novel Proprietary Mechanism for APOE4 In Alzheimer’s Disease     1/17/2017
Probiodrug AG Announces Completion Of Recruitment For The SAPHIR Phase 2a Study Of Glutaminyl Cyclase Inhibitor PQ912 In Early Alzheimer's Disease Patients     1/9/2017
NeuroGenetic Pharmaceuticals, Inc. Completes Phase 1 Clinical Trials For NGP 555 To Treat And Prevent Alzheimer’s Disease; Shown As Safe And Well-Tolerated In Healthy Volunteers     1/9/2017
Recombinant Technologies, LLC Release: Company Receives Phase II SBIR Grant To Develop AmyTrap for Treatment of Alzheimer’s Disease     1/6/2017
ProMis Neurosciences Declares PMN 310 Its First Lead Product For Development In Alzheimer's Disease     1/5/2017
Neuronix Ltd. Reports Positive Results From Its Multi-Center Alzheimer's Study At The Clinical Trials In Alzheimer's Disease (CTAD) Conference     1/4/2017
Alzamend Neuro Launches Regulation A+ Tier II SEC Qualified Offering     1/4/2017
Axsome (AXSM) Receives FDA Clearance Of IND For Phase II/III Trial Of AXS-05 In Alzheimer’s Disease Agitation     1/3/2017